Ridinilazole clinical trials
Also written SMT19969.
How each study uses ridinilazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Summit Therapeutics (4)
Studies
Open first, then newest update. How each study uses ridinilazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile InfectionCompletedPhase 3Summit TherapeuticsNCT03595553Written as Ridinilazole
- Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent SubjectsTerminatedPhase 3Summit TherapeuticsNCT04802837Written as Ridinilazole
- A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)CompletedPhase 2Summit TherapeuticsNCT02784002Written as Ridinilazole
- A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)CompletedPhase 2Summit TherapeuticsNCT02092935Written as SMT19969
Codes
What other systems call ridinilazole · ClinicalTrials.gg INT000318
- MeSH (NLM) C000601750ridinilazoleConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 06DX01190RRIDINILAZOLEConfirmed FDA, NLM, Wikidata
- Wikidata Q25102246RidinilazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152212RidinilazoleOne source FDA
- DrugBank DB15308One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000601750 | ridinilazole | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 06DX01190R | RIDINILAZOLE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q25102246 | Ridinilazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152212 | Ridinilazole | One source FDA |
| DrugBank | DB15308 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.